| Ecler Ercole Jaqua, MD | |
|
25455 Barton Rd Ste 204b, Loma Linda, CA 92354-3130 | |
| (909) 558-6600 | |
| Not Available |
| Full Name | Ecler Ercole Jaqua |
|---|---|
| Gender | Female |
| Speciality | Geriatric Medicine |
| Experience | 18 Years |
| Location | 25455 Barton Rd Ste 204b, Loma Linda, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003235235 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | A143997 (California) | Secondary |
| 207QG0300X | Family Medicine - Geriatric Medicine | A143997 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loma Linda University Medical Center | Loma linda, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faculty Physicians And Surgeons Of Llusm | 1153227814 | 1053 |
| Sac Health System | 4385533579 | 159 |
News Archive
Last month on a prominent nationally syndicated radio show, Dr. Rafael Pelayo, Associate Professor at the Stanford Sleep Disorders Clinic at Stanford University School of Medicine, recommended the Ecotones Duet Sleep Sound Machine as part of a healthy sleep plan for people trying to achieve a better night's sleep with minimal use of drugs.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
The U.S. Food and Drug Administration has approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.
Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.
Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.
› Verified 6 days ago
| Entity Name | Faculty Physicians And Surgeons Of Llusm |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205009917 PECOS PAC ID: 1153227814 Enrollment ID: O20031211000981 |
News Archive
Last month on a prominent nationally syndicated radio show, Dr. Rafael Pelayo, Associate Professor at the Stanford Sleep Disorders Clinic at Stanford University School of Medicine, recommended the Ecotones Duet Sleep Sound Machine as part of a healthy sleep plan for people trying to achieve a better night's sleep with minimal use of drugs.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
The U.S. Food and Drug Administration has approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.
Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.
Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.
› Verified 6 days ago
| Entity Name | Sac Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013935923 PECOS PAC ID: 4385533579 Enrollment ID: O20040315000608 |
News Archive
Last month on a prominent nationally syndicated radio show, Dr. Rafael Pelayo, Associate Professor at the Stanford Sleep Disorders Clinic at Stanford University School of Medicine, recommended the Ecotones Duet Sleep Sound Machine as part of a healthy sleep plan for people trying to achieve a better night's sleep with minimal use of drugs.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
The U.S. Food and Drug Administration has approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.
Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.
Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ecler Ercole Jaqua, MD File # 54701, Los Angeles, CA 90074-4701 Ph: (909) 558-6600 | Ecler Ercole Jaqua, MD 25455 Barton Rd Ste 204b, Loma Linda, CA 92354-3130 Ph: (909) 558-6600 |
News Archive
Last month on a prominent nationally syndicated radio show, Dr. Rafael Pelayo, Associate Professor at the Stanford Sleep Disorders Clinic at Stanford University School of Medicine, recommended the Ecotones Duet Sleep Sound Machine as part of a healthy sleep plan for people trying to achieve a better night's sleep with minimal use of drugs.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
The U.S. Food and Drug Administration has approved Risperdal (risperidone) for the treatment of schizophrenia in adolescents, ages 13 to 17, and for the short-term treatment of manic or mixed episodes of bipolar I disorder in children and adolescents ages 10 to 17.
Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.
Researchers at Washington University School of Medicine in St. Louis have found a key difference in the brains of people with Alzheimer's disease and those who are cognitively normal but still have brain plaques that characterize this type of dementia.
› Verified 6 days ago
Mark S Sutton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25455 Barton Rd, Suite 204b, Loma Linda, CA 92354 Phone: 909-558-6600 | |
Lauren Simon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25455 Barton Rd, Suite 204b, Loma Linda, CA 92354 Phone: 909-558-6600 | |
Barbara Orr, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 25455 Barton Rd, Ste 204b, Loma Linda, CA 92354 Phone: 909-558-6600 | |
Victoria V Teppone, FNP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25455 Barton Rd, Loma Linda, CA 92354 Phone: 909-558-6600 | |
Dr. Prashanth Gowda, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: Va Loma Linda Health Care System, 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Roger D. Woodruff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 25455 Barton Rd Ste 206a, Loma Linda, CA 92354 Phone: 909-558-6505 Fax: 909-558-6701 |